Publication | Closed Access

Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay

Hematological MalignancyLymphoid NeoplasiaOncologyMedicineMixed-phenotype Acute LeukemiaHematologyImmunologyPathologyTal-1 DeletionAdult T-cell Leukemia-lymphomaMolecular DiagnosticsCancer ResearchMinimal Residual Disease